美国基因与细胞治疗学会(ASGCT)第25届年会。华盛顿特区/Virtual - 2022年5月16日至19日

IF 0.2 4区医学 Q4 Medicine Drugs of The Future Pub Date : 2022-01-01 DOI:10.1358/dof.2022.47.8.3455366

R. Surià Albà

{"title":"美国基因与细胞治疗学会(ASGCT)第25届年会。华盛顿特区/Virtual - 2022年5月16日至19日","authors":"R. Surià Albà","doi":"10.1358/dof.2022.47.8.3455366","DOIUrl":null,"url":null,"abstract":"The American Society of Gene and Cell Therapy (ASGCT) held its 25th annual meeting in person in Washington, D.C., May 16-19. Virtual attendance was also an option offered due to the COVID-19 pandemic. The ASGCT annual meeting is the largest event focused on genetic and cellular therapies to prevent and cure human diseases. A multidisciplinary program was presented with nearly 1,300 presentations, either in oral sessions or as posters, revealing the latest advances in gene and cellular therapies. This report focuses on a selection of the highlights from the conference.","PeriodicalId":11366,"journal":{"name":"Drugs of The Future","volume":"1 1","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"American Society of Gene and Cell Therapy (ASGCT) - 25th Annual Meeting. Washington, D.C./Virtual - May 16-19, 2022\",\"authors\":\"R. Surià Albà\",\"doi\":\"10.1358/dof.2022.47.8.3455366\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The American Society of Gene and Cell Therapy (ASGCT) held its 25th annual meeting in person in Washington, D.C., May 16-19. Virtual attendance was also an option offered due to the COVID-19 pandemic. The ASGCT annual meeting is the largest event focused on genetic and cellular therapies to prevent and cure human diseases. A multidisciplinary program was presented with nearly 1,300 presentations, either in oral sessions or as posters, revealing the latest advances in gene and cellular therapies. This report focuses on a selection of the highlights from the conference.\",\"PeriodicalId\":11366,\"journal\":{\"name\":\"Drugs of The Future\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2022-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drugs of The Future\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1358/dof.2022.47.8.3455366\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drugs of The Future","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1358/dof.2022.47.8.3455366","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 1

摘要

5月16日至19日，美国基因与细胞治疗学会(ASGCT)在华盛顿举行了第25届年会。由于新冠肺炎大流行，也提供了虚拟考勤选项。ASGCT年会是专注于预防和治愈人类疾病的遗传和细胞疗法的最大活动。一个多学科项目有近1300份报告，无论是口头会议还是海报，展示了基因和细胞治疗的最新进展。本报告重点介绍会议的一些重要内容。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

American Society of Gene and Cell Therapy (ASGCT) - 25th Annual Meeting. Washington, D.C./Virtual - May 16-19, 2022

The American Society of Gene and Cell Therapy (ASGCT) held its 25th annual meeting in person in Washington, D.C., May 16-19. Virtual attendance was also an option offered due to the COVID-19 pandemic. The ASGCT annual meeting is the largest event focused on genetic and cellular therapies to prevent and cure human diseases. A multidisciplinary program was presented with nearly 1,300 presentations, either in oral sessions or as posters, revealing the latest advances in gene and cellular therapies. This report focuses on a selection of the highlights from the conference.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Drugs of The Future 医学-药学

CiteScore

0.30

自引率

0.00%

发文量

审稿时长

6-12 weeks

期刊介绍： A leading international, peer-reviewed biomedical research journal publishing articles on topics emerging from the confluence of fields including chemistry, biology, pharmacology, genomics and medicine, and addressed to scientists and researchers involved in drug design, discovery and development, target identification and validation, and the preclinical and clinical development of treatments for common as well as rare and neglected diseases and conditions. The journal publishes monographs containing comprehensive product information on new compounds in development, including synthesis, preclinical pharmacology, pharmacokinetics and metabolism, safety, clinical studies and drug interactions, as well as review articles on a variety of topics, congress and meeting reports.